First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
★ Analysts see FY2027 revenue reaching $1.8B — +10.4% growth in a single year.
What Moves the Stock
1Annual Recurring Revenue (ARR) growth rate and net retention rate - indicates both new customer acquisition and expansion within existing accounts, critical for SaaS valuation multiples
2Enterprise customer count and average contract value (ACV) - signals market penetration and ability to move upmarket against competitors
3AI/ML product adoption metrics - percentage of customers using Document Understanding, Process Mining, or AI Center modules demonstrates platform evolution beyond legacy RPA
4Operating margin trajectory and path to sustained profitability - investor focus shifted from pure growth to efficient growth following 2021-2022 SaaS multiple compression
5Competitive win rates against Microsoft Power Automate and displacement risk - Microsoft's bundling strategy represents existential threat to standalone RPA vendors
6Annual Recurring Revenue (ARR) from platform subscriptions - estimated 85-90% of revenue, primarily enterprise customers with multi-year contracts
7Professional services and training - estimated 10-15% of revenue, lower margin implementation and consulting work
8Consumption-based AI/ML automation add-ons - growing segment as customers adopt Document Understanding and Process Mining modules
Watch on earnings: ARR growth rate and net dollar retention rate (quarterly earnings releases), Enterprise customer count (>$100K ARR) and average contract value trends, Non-GAAP operating margin and free cash flow margin progression toward sustained profitability.
One Sentence Summary:
UiPath: the story is balanced — annual recurring revenue (arr) growth rate and net retention rate - indicates both new customer acquisition and expansion within existing.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.